Medicare Enrolled

Dr. Mahesh Mansukhani, M.D.

Molecular Genetic Pathology (Pathology) Physician · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
622 W 168TH ST, New York, NY 10032
2123052646
Registered in NPPES since 2007
NPI: 1477692556 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mansukhani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mansukhani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mansukhani

Dr. Mahesh Mansukhani is a molecular genetic pathology physician in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mansukhani performed 912 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Mansukhani received a total of $811 from 2 pharmaceutical and/or device companies across 4 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mansukhani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 912 Medicare services $811 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
912
Medicare services
Bottom 31% in NY for molecular genetic pathology (pathology) physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Chromosome analysis for genetic defects, 100-300 cells
A laboratory test that examines 100 to 300 cells to analyze chromosomes for genetic defects.
353 $50 $220
DNA testing for genetic defects
A laboratory test that analyzes DNA to identify specific genetic abnormalities or mutations. This procedure is used to detect inherited conditions or predispositions associated with genetic defects.
168 $21 $100
Tissue culture for bone marrow and blood cell tumor disorders
A laboratory test that grows bone marrow or blood cells in a culture to analyze tumor disorders.
134 $141 $540
Additional chromosome analysis study
This procedure involves performing an additional karyotype analysis to examine chromosomes for genetic defects. It is billed as a separate study beyond the initial analysis.
115 $33 $140
Chromosome analysis for genetic defects
A laboratory test that examines 15 to 20 cells to check for genetic defects in the chromosomes.
110 $123 $660
Manual urine cell examination
A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells.
19 $501 $2,250
Chromosome analysis, 5 cells
A genetic test that examines the structure and number of chromosomes in five cells to identify defects.
13 $259 $940
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2018 ↗
$811
Total received (2018-2018)
Top 46% in NY for molecular genetic pathology (pathology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
2
Companies
4
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2018
$811

Payments by company (2018)

E.R. Squibb & Sons, L.L.C.
$795
VENTANA MEDICAL SYSTEMS, INC.
$16
Top 3 companies account for 100.0% of 2018 payments
Associated products mentioned in payments ›
BENCHMARK IHC/ISH PLATFORMS & REAGENTS · OPDIVO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a molecular genetic pathology physician in New York?
Compare molecular genetic pathology physicians in the New York area by procedure volume, costs, and industry payment transparency.
Browse molecular genetic pathology physicians nearby

Geographic Context

Molecular genetic pathology physicians in nearby ZIP areas
20
County median income
$104,553
Nearest hospital to ZIP centroid (approximate)
NEW YORK STATE PSYCHIATRIC INSTITUTE
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2018
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mansukhani is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mansukhani experienced with chromosome analysis for genetic defects, 100-300 cells?
Based on Medicare claims data, Dr. Mansukhani performed 353 chromosome analysis for genetic defects, 100-300 cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mansukhani receive payments from pharmaceutical companies?
Yes. Dr. Mansukhani received a total of $811 from 2 companies across 4 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mansukhani's costs compare to other molecular genetic pathology physicians in New York?
Dr. Mansukhani's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mansukhani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →